Navigation Links
Unigene's Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone
Date:12/12/2012

BOONTON, N.J., Dec. 12, 2012 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that the results of its successful Phase 2 clinical trial evaluating an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women has been published online by Bone, the Official Journal of the International Bone and Mineral Society. The article will be published in the paper version of the journal in the coming months.

This peer reviewed manuscript, entitled, "Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant Human Parathyroid Hormone [rhPTH(1-31)NH2] in Postmenopausal Women with Osteoporosis," provides the full efficacy and safety data from Unigene's Phase 2 clinical study of oral PTH in the treatment of osteoporosis in 97 postmenopausal women.  Kim Henriksen, MSc, PhD, Head of Musculoskeletal Diseases at Nordic Bioscience served as the lead author of the article, which was jointly prepared by authors from Nordic Bioscience, Unigene Laboratories, the Center for Clinical and Basic Research (CCBR) and GlaxoSmithKline (GSK).

Ashleigh Palmer, Unigene's Chief Executive Officer, stated, "We are extremely pleased that a peer-reviewed article detailing the positive Phase 2 results from our oral PTH program was published in such a prestigious scientific journal as Bone.  The data and analysis once again demonstrate the strength of Unigene's proprietary oral peptide drug delivery technology and the clinical potential and commercial viability of our oral PTH analog.  I would like to extend my congratulations to Dr. Henriksen for leading the publication effort and to the entire team of contributors from Nordic Bioscience, CCBR, GSK and Unigene for their tremendous wor
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
2. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
3. uniQure Initiates Phase I in Acute Intermittent Porphyria
4. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
5. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
6. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
7. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
8. Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
9. Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
10. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
11. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... -- Concord Medical Services Holdings Limited ("Concord Medical" ... leading specialty hospital management solution provider and operator ... imaging centers in China , ... under which Concord Medical Services (International) Pte Ltd, ... to acquire the Fortis Surgical Hospital from Fortis ...
(Date:3/26/2015)... -- The Burzynski Research Institute, Inc. (BRI) announced today that ... Department of Surgery at Kurume University Medical Center ... published. The study, a randomized non-blinded phase 2 ... adjuvant therapy with and without Antineoplastons A10/AS2-1 Injections ... A total of 65 patients, with histologically ...
(Date:3/26/2015)... Calif. , March 26, 2015 Huntington ... Gabriel Valley to perform transcatheter aortic valve replacement (TAVR), ... procedure is a revolutionary new way to replace an ... of a heart lung machine. The procedure ... team led by Azhil ( Alex) Durairaj , MD, ...
Breaking Medicine Technology:Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2
... , EXTON, Pa., Nov. 23 ... LaunchTrends (TM): Feraheme report, the second ... AMAG,s new IV iron product, Feraheme, through the first six months ... information from 50 unique Nephrologists and qualitative information from a subset ...
... , FORT WORTH, Texas, Nov. 23 ... of specialty medical products, announced that it has filed it Q3 2009 ... the developments during the 2009 calendar year. , Q3 2009 sales ... , Shareholder equity as of the Q3 2009 increased to $3,327,892 ...
Cached Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 6
(Date:3/27/2015)... Long Island, NY (PRWEB) March 27, 2015 ... objective, cancer-focused training and business criteria for the spa ... and services to clients who have experienced or are ... of the global Spafinder Wellness 365® Network, will be ... Spafinder.com and recognized as a provider of safe, therapeutic ...
(Date:3/27/2015)... 27, 2015 First Choice Emergency Room ... new facility is located 12665 W Lake Houston Pkwy, Houston, ... of Summerwood, I look forward to delivering the highest quality ... Facility Medical Director of First Choice Emergency Room Summerwood. ... made a donation to Summer Creek High School at First ...
(Date:3/27/2015)... On February 21, 2015, Choices Recovery ... Penthouse on the rooftop of the luxurious Beverly ... product TV and film placement producer, was the ... featured some of the world’s top providers of ... , “We were honored to have a place ...
(Date:3/27/2015)... Ticket Down is a reputable source of authentic ... Omaha, Nebraska on Friday, May 8th and Saturday, May 9th. ... be added in Omaha as Garth has done in other ... Brooks World Tour is continuing its run throughout the United ... and Trisha Yearwood will bring their act to Omaha, NE ...
(Date:3/27/2015)... CA (PRWEB) March 27, 2015 Endure ... Yoga for functional fitness athletes. This new program matches ... specific protocol for post-workout cool down. This program utilizes ... breath control and mental focus. , Karen Lefurgy, ... started practicing yoga long before I started Crossfit® training, ...
Breaking Medicine News(10 mins):Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2Health News:Choices Recovery Releases 'Salute to the Oscars' EcoLuxe Lounge Compilation Video 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:Endure Yoga Introduces WOD Recovery Yoga 2
... conscious folks around the world who get uncomfortable after a ... conducted recently in Spain have proven that eating 6-8 walnuts ... inflammatory changes that are triggered of in the walls of ... to be published in the Oct. 17 issue of the ...
... voluntarily recalled its lettuce after irrigation water samples tested ... days after the FDA relaxed its advisory against eating ... E. coli contamination was detected after a secondary water ... positive for it. How the water got contaminated is ...
... arrived in Bahrain to receive urgently needed medical treatment.// ... days as part of an agreement with the World Health ... to a call to help fund treatment for seriously ill ... the head of the newly established Organisation for Culturing and ...
... Although women in Mizoram are literate enough to understand the ... consume it in various forms making them the most cancer// ... National Family Health Survey (NFHS) shows more than 22 percent ... percent, said Jane R. Ralte, principal investigator of the state's ...
... adult is happy to come away from any physicians ... to prescribing medicines, as routinely done, would it be ... same prescription?. A researcher in the Lipid Metabolism Laboratory ... McDermott, PhD Research Center on Aging (USDA HNRCA) at ...
... from a three-year, $728,000 grant from the US Department ... F.// Connell School of Nursing has established a new ... degree program. Palliative care nursing provides care for patients ... is the first college or university in New England ...
Cached Medicine News:Health News:Walnuts May Help Fight Fat and Keep Arteries Supple 2Health News:Mizoram Women Under the Grip of Tobacco 2Health News:Exercise to be Prescribed for Robust Health in Elderly 2Health News:College Launches Palliative Care Nursing Program 2
... offers the Clareon to practices that require ... speed and efficacy. The versatility of the ... wide range of treatments that would typically ... need to worry about obsolescence because the ...
... advantages of the IPL Quantum DL and the ... other deeper vascular lesions. This cost-effective system is ... device or as an upgrade to the IPL ... of conditions including: Leg veins , ...
... of powerful, versatile, and innovative aesthetic treatments ... Pulsed Light and Laser System.,With StarLux you ... unit so theres no need to ... can choose among Laser, Intense Pulsed Light, ...
... Supplemental Confirmatory (Western Blot): The assay uses ... on their surface. The cells are fixed ... slide. Fixed, uninfected T-cells are provided as ... sample with HIV- I antibodies comes in ...
Medicine Products: